Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Directly Observed Therapy (DOT) in HIV-Infected Adolescents: Part A-Focus Groups

NCT00079729 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT00079729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00079729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Directly Observed Therapy (DOT) in HIV-Infected Adolescents: Part A-Focus Groups
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Observational
Overall status
Completed
Start date
April 30, 2004
Completion date
July 31, 2004
Enrollment
30
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections